title: The HIV/AIDS vaccine researchers' orientation to the process of preparing a US FDA application for an investigational new drug (IND): what it is all about and how you start by preparing for your pre-IND meeting.
authors.affiliation: Vaccine and Prevention Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, 6700-B Rockledge Dr., Room 4108, Bethesda, MD 20892-7628, USA. sshapiro@niaid.nih.gov
authors.forename: Stuart Z
authors.initials: SZ
authors.lastname: Shapiro
mesh_terms: D016915:AIDS Vaccines / Q000009:adverse effects / Q000276:immunology; D000818:Animals; D002986:Clinical Trials as Topic; D006801:Humans; D017387:Investigational New Drug Application; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016915:AIDS Vaccines